Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non‐CB1/CB2 Gi/o linked receptor
- 1 June 2004
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 142 (3) , 509-518
- https://doi.org/10.1038/sj.bjp.0705789
Abstract
Noladin ether has recently been reported to be an endocannabinoid, with selectivity for the cannabinoid (CB) CB1 receptor. In the present study, we investigated the effects of noladin ether in the rat isolated mesenteric arterial bed, cultured dorsal root ganglia (DRG) cells and human vanilloid (TRPV1)‐receptor‐expressing HEK293 cells (TRPV1‐HEK293 cells). Electrical field stimulation of the mesenteric bed evoked frequency‐dependent vasorelaxation due to the action of calcitonin gene‐related peptide (CGRP) released from sensory nerves. Noladin ether (0.1–3 μM) attenuated sensory neurogenic relaxation in a concentration‐dependent manner. Noladin ether (1 μM) reduced vasorelaxation at a submaximal frequency (8 Hz), from 57.3±6.8 to 23.3±3.8% (Pn=4). The inhibitory effects of noladin ether were unaffected by the CB1 antagonists SR141716A and LY320135, and the CB2 antagonist SR144528 (1 μM). Noladin ether had no effect on vasorelaxation elicited by exogenous CGRP or capsaicin. These data suggest that noladin ether is acting at a prejunctional site and no interaction with TRPV1 is involved. In mesenteric beds from pertussis toxin (PTX)‐pretreated rats, the inhibitory actions of noladin ether on sensory neurotransmission were abolished, indicating the involvement of Gi/o protein‐coupled receptors. Noladin ether evoked a concentration‐dependent increase in intracellular Ca2+ concentration in TRPV1‐HEK293 cells at 10 μM (36.5±3.2% of maximal capsaicin‐induced response), but it was a less potent agonist than both capsaicin and anandamide and at 1 μM it was essentially inactive. Noladin ether (1 μM) had no effect on capsaicin‐evoked Ca2+ responses in DRG cells, and produced no response alone, indicating it neither modulates nor acts directly on TRPV1 receptors. These data demonstrate that noladin ether attenuates sensory neurotransmission in rat mesenteric arteries via a non‐CB1 non‐CB2 PTX‐sensitive prejunctional site, independently of TRPV1 receptors. British Journal of Pharmacology (2004) 142, 509–518. doi:10.1038/sj.bjp.0705789Keywords
This publication has 31 references indexed in Scilit:
- Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian speciesJournal of Neurochemistry, 2003
- Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid ReceptorMolecular Pharmacology, 2003
- Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor‐dependent G‐protein activation in rat cerebellar membranesBritish Journal of Pharmacology, 2001
- Cannabinoid inhibition of the capsaicin‐induced calcium response in rat dorsal root ganglion neuronesBritish Journal of Pharmacology, 2001
- Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout MiceJournal of Neurochemistry, 2000
- Cloning and functional expression of a human orthologue of rat vanilloid receptor-1Pain, 2000
- The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)British Journal of Pharmacology, 2000
- Mesenteric Vasodilation Mediated by Endothelial Anandamide ReceptorsHypertension, 1999
- Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol ReceptorJournal of Biological Chemistry, 1999
- Acrylamide-induced autonomic neuropathy of rat mesenteric vessels: Histological and pharmacological studiesJournal of the Autonomic Nervous System, 1991